Larry Smith (@smithonstocks1) 's Twitter Profile
Larry Smith

@smithonstocks1

ID: 1314673360224346112

calendar_today09-10-2020 21:06:35

43 Tweet

282 Takipçi

32 Takip Edilen

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$NWBO Putting the extremely important peer reviewed JAMA article on DCVax-L in perspective smithonstocks.com/northwest-biot…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$nwbo If you suspect that NWBO stock price is being manipulated, you might want to read this. smithonstocks.com/why-i-believe-…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$nwbo Comments on FDA Guidance for Use of Contemporaneous External Controls; Importance for DCVax-L smithonstocks.com/northwest-biot…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$NWBO Investors don't own shares of NWBO. They are owned by CEDE, a subsidiary of DTCC which in turn is owned by Wall Street firms. You own a fungible, digital derivative of registered shares which is key to creation of counterfeit shares. See smithonstocks.com/part-8-illegal…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$NWBO Feuerstein says there is no spoofing or market manipulation. His old firm TheStreet.com disagrees. thestreet.com/memestocks/red… Also Citadel just paid a $10 million fine in Japan for spoofing.

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$NWBO $GNS Creating counterfeit shares through illegal naked shorting is at the heart of Wall Street's rampant manipulation of securities, which by some estimates accounts for as much as 20% of Street profits. In part, this is how it is done with stocks. smithonstocks.com/part-7-illegal…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$NWBO Creating counterfeit shares through illegal naked shorting is at the heart of Wall Street's rampant manipulation of securities, which by some estimates accounts for as much as 20% of Street profits. In part, this is how it is done with stocks. smithonstocks.com/part-7-illegal…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$nwbo Feuerstein continues to gaslight the DCVax-L phase 3 trial falsely claiming that the endpoint was PFS. Here are the actual facts. smithonstocks.com/explanation-of…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$nwbo The commercial licensing of Sawston likely confers to it a value of several hundred million dollars. This is a new and very important part of the NWBO inv thesis apart from DCVax-L. See my report. smithonstocks.com/northwest-biot…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$nwbo Why I believe that NWBO has been the subject of a collusion between market makers and hedge funds to artificially drive the price to levels orders of magnitude below it would be without the manipulation. smithonstocks.com/why-i-believe-…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

I wrote this report on the importance of the approval for the commercial manufacturing of DCVax-L at Sawston last April. Thought I would republish. smithonstocks.com/northwest-biot…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$nwbo I have summarized my latest thoughts on NWBO in a report “Highly Probable UK Approval of DCVax-L in 1H, 2024 Would Be a Crowning Achievement for Northwest Biotherapeutics”. This can be accessed free of charge at this link. smithonstocks.com/highly-probabl…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

I published a report last week "Highly Probable UK Approval of DCVax-L in 1H, 2024 Would Be a Crowning Achievement" for Northwest Biotherapeutics smithonstocks.com/highly-probabl… Firewall issues prevented some from seeing it, but this has been corrected. The report is free.

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$NWBO I have just published a new report on the lawsuit. It can be accessed at this link. smithonstocks.com/denial-of-the-… Ignore the message that you need to subscribe to access the report. It is free.

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

The decision on Citadel, et al's motion to dismiss is likely to be released in four to six weeks. This leads me to republish a report on this issue earlier this year. smithonstocks.com/denial-of-the-…

Larry Smith (@smithonstocks1) 's Twitter Profile Photo

$nwbo I have taken the transcript from Linda Power’s comments at the annual meeting and edited and organized them to make for easier reading. It contains a wealth of valuable information. I have also included my key takeaways. The report is free . smithonstocks.com/northwest-biot…